Evidence map›Paper›PMID 26487712›Full record

ArticleProtein engineering, design & selection : PEDS2015

A solenoid design for assessing determinants of parallel β-sheet registration.

Ellen M White, Andrew D Miranker

Abstract read
In one paragraph

Article in Protein engineering, design & selection : PEDS, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ellen M WhiteDepartment of Molecular Biophysics and Biochemistry, Yale University, 260 Whitney Avenue, New Haven, CT 06520-8114, USA.
Andrew D MirankerDepartment of Molecular Biophysics and Biochemistry, Yale University, 260 Whitney Avenue, New Haven, CT 06520-8114, USA andrew.miranker@yale.edu.

Funding

Skill Development for Diverse Scientific Careers: A New Course Predoctoral Program in Cellular and Molecular BiologyT32GM007223 · NIGMS · YALE UNIVERSITY · PI BASERGA, SUSAN J · 1985 to 2019
$31.0M
An orderly approach to toxic mechanism by disorderly peptidesR01GM102815 · NIGMS · YALE UNIVERSITY · PI MIRANKER, ANDREW D., RHOADES, ELIZABETH · 2012 to 2015
$1.5M
Insight into pathological self assembly using alpha-helical mimeticsR01GM094693 · NIGMS · YALE UNIVERSITY · PI MIRANKER, ANDREW D. · 2011 to 2014
$1.2M
NIGMS NIH HHS GM094693NIGMS NIH HHS GM102815NIGMS NIH HHS T32 GM007223NIGMS NIH HHS T32GM007223
6 · The paper itself

Abstract

A novel protein construct is presented that combines a homotrimeric, triple-stranded β-helix as a guest to a homotrimeric foldon unit from bacteriophage T4 fibritin. The β-helical solenoid selected is short (46 residues) and is part of a subdomain of the T4 cell-puncturing device. The resultant design is trimeric and displays greatly enhanced stability over each sub-component alone. The intended goal is a design that will enable evaluation of sequence determinants that promote in-register versus out-of-register parallel β-sheet homotrimerization. Towards that end, the importance of a set of three buried salt-bridges was evaluated by converting them to residues otherwise consistently found throughout the natural solenoid at the same positions. The critical role of the charged residues in the salt-bridges was evident in that their elimination resulted in amyloid-like aggregation.

Indexed as

Models, MolecularProtein Structure, SecondaryAmino Acid SequenceAmyloidBiochemistryFluorescent DyesMolecular Sequence DataViral ProteinsAmyloidfibritin protein, Enterobacteria phage T4Fluorescent DyesViral Proteinsamyloidfoldonparallel β-sheetsalt-bridgeβ-helix

Identifiers

PMID26487712
PMCPMC4646161

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.